This is wonderful news regarding new treatment options for the SD community.
Read the full press release from Novartis: www.novartis.com/news/media-r...
#ChronicHives #Urticaria #Allergy #Dermatology #BTKinhibitor #SD
@allergyasthmahq.bsky.social
@allergyasthmahq.bsky.socialThis is wonderful news regarding new treatment options for the SD community.
Read the full press release from Novartis: www.novartis.com/news/media-r...
#ChronicHives #Urticaria #Allergy #Dermatology #BTKinhibitor #SD
@pharmaphorum.bsky.social#Novartis' oral #BTKinhibitor #Rhapsido has had its label expanded in the #US to include a second indication, #symptomaticdermographism (SD), which causes #chronichives.
@gmj-georgia.bsky.socialTriple therapy breakthrough: Adding pirtobrutinib to venetoclax-rituximab significantly extends progression-free survival in patien… #BTKinhibitor #Chroniclymphocyticleukemia #Pirtobrutinib #Rituximab #Venetoclax #BTKinhibitor #Chroniclymphocyticleukemia #Pirtobrutinib #Rituximab #Venetoclax h…